Market Commentary

Rep Steube on Intelligence Committee Buys IonQ Weeks Before DARPA

Turra Rasheed
16 Apr 2026 · 1 minute read

Rep. Greg Steube disclosed purchasing IonQ (IONQ:US) shares on March 17-18, 2026, weeks before the company announced a major DARPA contract and an Air Force Research Lab breakthrough.

On April 14, IonQ revealed it had been selected for DARPA’s Heterogeneous Architectures for Quantum (HARQ) program to develop high-speed quantum interconnects. At the same time, the company announced a photonic entanglement breakthrough with the Air Force Research Laboratory. The stock jumped over 14% in a single day.

What makes this trade stand out is Steube’s position on the House Intelligence Committee. That committee oversees the NSA and Defense Intelligence agencies, the exact entities involved in funding, classifying, and receiving briefings on U.S. quantum computing programs.

Steube bought the stock in his IRA in the range of $1,001-$15,000. At the time of purchase, IonQ had been volatile, but the subsequent DARPA win and technical milestone delivered an immediate pop.

This isn’t the first time congressional stock trades in sensitive defense-tech sectors have drawn scrutiny. With quantum computing increasingly viewed as critical national security infrastructure, the timing,  buying well before the public contract announcement, has sparked questions about access to non-public information.

Under current rules, members of Congress must disclose trades within 45 days. Whether this was exceptional foresight or something that warrants closer review, the optics are striking: a lawmaker with direct oversight of intelligence agencies profiting from a company that just secured major defense quantum contracts.

As momentum grows for stricter congressional stock trading restrictions, cases like this continue to highlight the blurred line between policymaking and personal portfolios in cutting-edge defense technology.